Abstract:2-Aminopurine (2-AP) inhibits specific kinases that phosphorylate the ␣ subunit of eukaryotic translation initiation factor 2. One of these, PKR, is also involved in signal transduction. We show here that 2-AP selectively inhibits expression of tumor necrosis factor alpha (TNF-␣) mRNA in primary human lymphoid cells. 2-AP does not inhibit transcription of the human TNF-␣ gene, nor does it affect mRNA stability. Instead, the flow of short-lived precursor transcripts into mature TNF-␣ mRNA is blocked. When 2-AP … Show more
“…2AP blocks the splicing of pre-mRNA transcripts. But, as shown previously, TNF-␣ pre-mRNA transcripts are unstable (11). As Be stimulation continues to drive the synthesis of pre-mRNA transcripts, we observed a slight increase in the levels relative to the profound decrease in levels in the presence of PTX.…”
Section: Discussionsupporting
confidence: 47%
“…Our previous studies show that the percentage of Be-specific CD4 ϩ T cells are found in the range of 1.4-29% in CBD BAL cells (2). Be-induced TNF-␣ pre-mRNA upregulation was inhibited by PTX, a transcription inhibitor (12,13), and the splicing of TNF-␣ pre-mRNA into mature mRNA transcripts was inhibited by 2AP, a splicing inhibitor (11). In addition, the data indicate that this Be-induced TNF-␣ production was associated with Be-specific upregulation of AP-1 and NF-B transcription factors in the nuclei of CBD BAL cells.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, we tested the hypothesis that the upregulation of Be-stimulated CBD BAL cell TNF-␣ mRNA and protein was transcription-dependent. To do this, we used pentoxifylline (PTX) to inhibit transcription of the TNF-␣ gene and 2-aminopurine (2AP) to inhibit the splicing of TNF-␣ pre-mRNA into mature mRNA transcripts (11)(12)(13). If Be-induced CBD BAL T cell TNF-␣ production is transcription-dependent, a second goal of our study was determining whether Be exposure upregulates nuclear transcription factors associated with activation of the TNF-␣ gene promoter.…”
Section: Clinical Relevancementioning
confidence: 99%
“…PTX inhibited the formation of TNF-␣ pre-mRNA transcripts and 2AP inhibited the splicing of these TNF-␣ pre-mRNA transcripts into mature TNF-␣ mRNA transcripts (11)(12)(13). Real-time PCR analysis was performed on treated and untreated control cells after 6 h of Be or LPS exposure.…”
Section: Be Induces Tnf-␣ Gene Transcriptionmentioning
confidence: 99%
“…Real-time RT-PCR was also used to determine TNF-␣ pre-and mature mRNA levels, using a subset of BAL cells from four subjects with CBD, in the absence and presence of 2AP, a splicing inhibitor (11), or PTX, a transcription inhibitor (12,13). For these experiments, cell concentration was adjusted to 1 ϫ 10 6 cells/ml of complete medium, and 200-l aliquots were then cultured in five wells per treatment.…”
Beryllium (Be)-antigen presentation to Be-specific CD4 ϩ T cells from the lungs of patients with chronic beryllium disease (CBD) results in T cell proliferation and TNF-␣ secretion. We tested the hypothesis that Be-induced, CBD bronchoalveolar lavage (BAL) T cell, transcription-dependent, TNF-␣ secretion was accompanied by specific transcription factor upregulation. After 6 h of Be stimulation, CBD BAL cells produced a median of 883 pg/ml TNF-␣ (range, 608-1,275 pg/ml) versus 198 pg/ml (range, 116-245 pg/ml) by unstimulated cells. After 12 h CBD BAL cells produced a median of 2,963 pg/ml (range, 99-9,424 pg/ml) TNF-␣ versus 55 pg/ml (range, 0-454) by unstimulated cells. Using real-time RT-PCR, Be-stimulated TNF-␣ production at 6 h was preceded by a 5-fold increase in TNF-␣ premRNA copy number:-actin copy number (Be median ratio 0.21; unstimulated median ratio 0.04). The median ratio of mature TNF-␣ mRNA:-actin mRNA was upregulated 1.4-fold (Be median ratio 0.17; unstimulated median ratio 0.12). Be exposure in the presence of the transcription inhibitor pentoxifylline (PTX) decreased CBD BAL cell TNF-␣ pre-mRNA levels Ͼ 60%, whereas treatment with the mRNA splicing inhibitor 2-aminopurine (2AP) decreased levels 40% relative to Be exposure alone. PTX treatment decreased mature TNF-␣ mRNA levels 50% while 2AP decreased levels Ͼ 80%, relative to Be exposure alone. Beryllium exposure specifically upregulated transcription factors AP-1 and NF-B. The data suggest that Be exposure induces transcription-dependent TNF-␣ production, potentially due to upregulation of specific transcription factors.
“…2AP blocks the splicing of pre-mRNA transcripts. But, as shown previously, TNF-␣ pre-mRNA transcripts are unstable (11). As Be stimulation continues to drive the synthesis of pre-mRNA transcripts, we observed a slight increase in the levels relative to the profound decrease in levels in the presence of PTX.…”
Section: Discussionsupporting
confidence: 47%
“…Our previous studies show that the percentage of Be-specific CD4 ϩ T cells are found in the range of 1.4-29% in CBD BAL cells (2). Be-induced TNF-␣ pre-mRNA upregulation was inhibited by PTX, a transcription inhibitor (12,13), and the splicing of TNF-␣ pre-mRNA into mature mRNA transcripts was inhibited by 2AP, a splicing inhibitor (11). In addition, the data indicate that this Be-induced TNF-␣ production was associated with Be-specific upregulation of AP-1 and NF-B transcription factors in the nuclei of CBD BAL cells.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, we tested the hypothesis that the upregulation of Be-stimulated CBD BAL cell TNF-␣ mRNA and protein was transcription-dependent. To do this, we used pentoxifylline (PTX) to inhibit transcription of the TNF-␣ gene and 2-aminopurine (2AP) to inhibit the splicing of TNF-␣ pre-mRNA into mature mRNA transcripts (11)(12)(13). If Be-induced CBD BAL T cell TNF-␣ production is transcription-dependent, a second goal of our study was determining whether Be exposure upregulates nuclear transcription factors associated with activation of the TNF-␣ gene promoter.…”
Section: Clinical Relevancementioning
confidence: 99%
“…PTX inhibited the formation of TNF-␣ pre-mRNA transcripts and 2AP inhibited the splicing of these TNF-␣ pre-mRNA transcripts into mature TNF-␣ mRNA transcripts (11)(12)(13). Real-time PCR analysis was performed on treated and untreated control cells after 6 h of Be or LPS exposure.…”
Section: Be Induces Tnf-␣ Gene Transcriptionmentioning
confidence: 99%
“…Real-time RT-PCR was also used to determine TNF-␣ pre-and mature mRNA levels, using a subset of BAL cells from four subjects with CBD, in the absence and presence of 2AP, a splicing inhibitor (11), or PTX, a transcription inhibitor (12,13). For these experiments, cell concentration was adjusted to 1 ϫ 10 6 cells/ml of complete medium, and 200-l aliquots were then cultured in five wells per treatment.…”
Beryllium (Be)-antigen presentation to Be-specific CD4 ϩ T cells from the lungs of patients with chronic beryllium disease (CBD) results in T cell proliferation and TNF-␣ secretion. We tested the hypothesis that Be-induced, CBD bronchoalveolar lavage (BAL) T cell, transcription-dependent, TNF-␣ secretion was accompanied by specific transcription factor upregulation. After 6 h of Be stimulation, CBD BAL cells produced a median of 883 pg/ml TNF-␣ (range, 608-1,275 pg/ml) versus 198 pg/ml (range, 116-245 pg/ml) by unstimulated cells. After 12 h CBD BAL cells produced a median of 2,963 pg/ml (range, 99-9,424 pg/ml) TNF-␣ versus 55 pg/ml (range, 0-454) by unstimulated cells. Using real-time RT-PCR, Be-stimulated TNF-␣ production at 6 h was preceded by a 5-fold increase in TNF-␣ premRNA copy number:-actin copy number (Be median ratio 0.21; unstimulated median ratio 0.04). The median ratio of mature TNF-␣ mRNA:-actin mRNA was upregulated 1.4-fold (Be median ratio 0.17; unstimulated median ratio 0.12). Be exposure in the presence of the transcription inhibitor pentoxifylline (PTX) decreased CBD BAL cell TNF-␣ pre-mRNA levels Ͼ 60%, whereas treatment with the mRNA splicing inhibitor 2-aminopurine (2AP) decreased levels 40% relative to Be exposure alone. PTX treatment decreased mature TNF-␣ mRNA levels 50% while 2AP decreased levels Ͼ 80%, relative to Be exposure alone. Beryllium exposure specifically upregulated transcription factors AP-1 and NF-B. The data suggest that Be exposure induces transcription-dependent TNF-␣ production, potentially due to upregulation of specific transcription factors.
The tumor necrosis factors (TNF-alpha and lymphotoxin, or LT-alpha) are important mediators of the immune and inflammatory responses, and it has been proposed that a positive feedback loop could boost the expression of the TNF to sufficiently high levels to fend off infections. To investigate this phenomenon and its biological consequences, we have generated LT-alpha/TNF-alpha knockout mice and compared mice having one or two functional LT-alpha/TNF-alpha alleles. In response to lipopolysaccharide (LPS) stimulation, TNF-alpha levels in the circulation or in the supernatant of macrophage cultures were 20- to 100-fold lower in heterozygous samples than in their wild-type counterparts. This differential increased with the intensity of stimulation and throughout the response, supporting the involvement of a positive feedback loop. Moreover, the heterozygous mice had an increased bacterial load following Listeria monocytogenes infection and exhibited a bimodal response to the association of D-galactosamine and LPS which was similar to that of wild-type mice at low doses of LPS and more like that of homozygous mutants at high doses. These results therefore establish the biological importance of the nonlinear response of TNF-alpha levels to gene dosage, and these mice provide a unique tool to study how the propensity to produce TNF can determine the immunological fitness of individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.